News-Medical.Net on MSN
Psoriasis linked to higher risk of age-related macular degeneration
New research presented today at the European Academy of Dermatology and Venereology (EADV) Congress 2025 reveals that people ...
Everyday Health on MSN
Psoriasis and Bipolar Disorder: What’s the Connection?
Explore the connection between psoriasis and bipolar disorder, their shared risk factors, and strategies for managing both conditions effectively.
Everyday Health on MSN
Psoriasis on the Knees and Elbows: What It Looks Like, How to Treat It
The knees and elbows are common spots for psoriasis. Here’s what those inflamed patches look like, plus the latest on ...
Raptiva is an injection for adults with moderate to severe plaque psoriasis The drug suppresses T-cells, which makes it decrease immune system function WASHINGTON (CNN)-- The government is warning ...
Older adults with psoriasis are more likely to develop age-related macular degeneration, though biologics may play a role in ...
Dealing with the itchy, scaly patches that come with psoriasis is difficult enough. But having psoriasis puts you at risk of developing psoriatic arthritis, an inflammatory condition that impacts the ...
Besides mosquito bites, other causes of itchy bumps on your skin may include hives, other bug bites like flea bites, and ...
Paris, France, Thursday, 18 September 2025) New research presented today at the European Academy of Dermatology and Venereology (EADV) Congress 2025 ...
HealthDay on MSN
Study finds unexpected Ozempic, Zepbound benefits for psoriasis
People with psoriasis might receive unexpected benefits from cutting-edge weight loss drugs like Ozempic and Zepbound, German researchers said in a new study.
For almost two months now, I’ve had bumps on the back, sides and crown of my head. They itch all the time – and even more when I get hot. When I scratch, I see white or brown flakes. My dermatologist ...
Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 Filing based on four Phase 3 studies that met all primary and co-primary endpoints.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results